Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06859450
PHASE2/PHASE3

Local Antibiotic Delivery for Community Acquired Pneumonia

Sponsor: Copenhagen Respiratory Research

View on ClinicalTrials.gov

Summary

A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without pre-existing lung disease.

Official title: Local Antibiotic Delivery for Community Acquired Pneumonia - Pilot Study (LANDCAP1)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2025-03-04

Completion Date

2028-09-01

Last Updated

2025-03-10

Healthy Volunteers

No

Interventions

DRUG

Levofloxacin

Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.

DRUG

Placebo

Add-on treatment of inhaled Levofloxacin 240mg twice daily or placebo (saline) twice daily for up to 3 days while admitted.